CN105616406B - 外用局部异噁唑啉制剂 - Google Patents

外用局部异噁唑啉制剂 Download PDF

Info

Publication number
CN105616406B
CN105616406B CN201610036739.7A CN201610036739A CN105616406B CN 105616406 B CN105616406 B CN 105616406B CN 201610036739 A CN201610036739 A CN 201610036739A CN 105616406 B CN105616406 B CN 105616406B
Authority
CN
China
Prior art keywords
compound
solvent
formulation
topical
formulations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201610036739.7A
Other languages
English (en)
Chinese (zh)
Other versions
CN105616406A (zh
Inventor
S.富克斯
A.R.赫克罗思
R.米勒
H.威廉斯
H.佐勒
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Intervet International BV
Original Assignee
Intervet International BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43971048&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CN105616406(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Intervet International BV filed Critical Intervet International BV
Publication of CN105616406A publication Critical patent/CN105616406A/zh
Application granted granted Critical
Publication of CN105616406B publication Critical patent/CN105616406B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/72—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
    • A01N43/80—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms five-membered rings with one nitrogen atom and either one oxygen atom or one sulfur atom in positions 1,2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Environmental Sciences (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Agronomy & Crop Science (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
CN201610036739.7A 2010-12-27 2011-12-22 外用局部异噁唑啉制剂 Active CN105616406B (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP10197089 2010-12-27
EP10197089.5 2010-12-27
US201161430240P 2011-01-06 2011-01-06
US61/430240 2011-01-06
CN201180062852.8A CN103260621B (zh) 2010-12-27 2011-12-22 外用局部异噁唑啉制剂

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CN201180062852.8A Division CN103260621B (zh) 2010-12-27 2011-12-22 外用局部异噁唑啉制剂

Publications (2)

Publication Number Publication Date
CN105616406A CN105616406A (zh) 2016-06-01
CN105616406B true CN105616406B (zh) 2019-12-13

Family

ID=43971048

Family Applications (2)

Application Number Title Priority Date Filing Date
CN201180062852.8A Active CN103260621B (zh) 2010-12-27 2011-12-22 外用局部异噁唑啉制剂
CN201610036739.7A Active CN105616406B (zh) 2010-12-27 2011-12-22 外用局部异噁唑啉制剂

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CN201180062852.8A Active CN103260621B (zh) 2010-12-27 2011-12-22 外用局部异噁唑啉制剂

Country Status (19)

Country Link
US (4) US9173870B2 (enExample)
EP (1) EP2658542B2 (enExample)
JP (3) JP6002148B2 (enExample)
KR (2) KR102027723B1 (enExample)
CN (2) CN103260621B (enExample)
AU (2) AU2016201954B2 (enExample)
BR (1) BR112013015503A2 (enExample)
CA (1) CA2822839C (enExample)
DK (1) DK2658542T4 (enExample)
ES (1) ES2908094T5 (enExample)
FI (1) FI2658542T4 (enExample)
HU (1) HUE058291T2 (enExample)
MX (2) MX356926B (enExample)
NZ (1) NZ611476A (enExample)
PL (1) PL2658542T5 (enExample)
PT (1) PT2658542T (enExample)
RU (2) RU2633061C2 (enExample)
WO (1) WO2012089622A2 (enExample)
ZA (1) ZA201304514B (enExample)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE058291T2 (hu) * 2010-12-27 2022-07-28 Intervet Int Bv Topikális lokalizált izoxazolin formuláció
KR101992589B1 (ko) * 2010-12-27 2019-06-24 인터벳 인터내셔널 비.브이. 글리코푸롤을 포함하는 국소 적용 이속사졸린 제제
PT2755473T (pt) 2011-09-12 2019-03-25 Boehringer Ingelheim Animal Health Usa Inc Composições parasiticidas compreendendo um agente ativo de isoxazolina, métodos e suas utilizações
PL232463B1 (pl) 2012-02-06 2019-06-28 Merial Inc Miękka, nadająca się do żucia kompozycja weterynaryjna do leczenia i/lub zapobiegania infekcji lub inwazji pasożytniczej u zwierzęcia oraz jej zastosowanie
JO3626B1 (ar) 2012-02-23 2020-08-27 Merial Inc تركيبات موضعية تحتوي على فيبرونيل و بيرميثرين و طرق استخدامها
RU2765231C2 (ru) * 2012-04-04 2022-01-26 Интервет Интернэшнл Б.В. Мягкие жевательные фармацевтические продукты
EP3063144B1 (en) 2013-11-01 2021-09-08 Boehringer Ingelheim Animal Health USA Inc. Antiparasitic and pesticidal isoxazoline compounds
BR112016014216B1 (pt) 2013-12-20 2022-08-30 Intervet International B.V. Usos de um composto isoxazolina
JP6581586B2 (ja) * 2013-12-20 2019-09-25 インターベット インターナショナル ベー． フェー． イソオキサゾリン組成物および動物における寄生虫侵襲の予防または処置におけるその使用
CA2945766C (en) 2014-04-17 2023-09-26 Merial, Inc. Use of malononitrile compounds for protecting animals from parasites
WO2016022066A1 (en) 2014-08-04 2016-02-11 Jerry Tan Eye Surgery Pte Ltd Pharmaceutical compositions for demodex related blepharitis and eyelid crusting
AU2015371175B2 (en) 2014-12-22 2021-03-04 Intervet International B.V. Use of isoxazoline compounds for treating demodicosis
UY36570A (es) 2015-02-26 2016-10-31 Merial Inc Formulaciones inyectables de acción prolongada que comprenden un agente activo isoxazolina, métodos y usos de las mismas
US10081656B2 (en) 2015-05-20 2018-09-25 Merial, Inc. Anthelmintic depsipeptide compounds
US20170333305A1 (en) * 2016-05-23 2017-11-23 Microban Products Company Topical skin product having retention property
CN110381738B (zh) 2016-10-14 2021-07-16 勃林格殷格翰动物保健美国公司 农药的和杀寄生物的乙烯基异噁唑啉化合物
WO2018093920A1 (en) 2016-11-16 2018-05-24 Merial, Inc. Anthelmintic depsipeptide compounds
WO2019036407A1 (en) 2017-08-14 2019-02-21 Merial, Inc. PYRAZOLE-ISOXAZOLINE COMPOUNDS WITH PESTICIDE AND PARASITICIDE ACTIVITY
AU2018372008B2 (en) * 2017-11-23 2024-03-28 Ceva Sante Animale Composition containing moxidectin for treating parasites infestations
DK3723739T3 (da) 2017-12-15 2024-06-17 Tarsus Pharmaceuticals Inc Isoxazolin-parasiticidformuleringer og deres anvendelse til behandling af blepharitis
AR113997A1 (es) * 2017-12-21 2020-07-08 Intervet Int Bv Composiciones antiparasitarias para unción dorsal continua
PE20211275A1 (es) 2018-07-09 2021-07-19 Boehringer Ingelheim Animal Health Usa Inc Compuestos heterociclicos antihelminticos
EP3883648A1 (en) 2018-11-20 2021-09-29 Boehringer Ingelheim Animal Health USA Inc. Indazolylcyanoethylamino compound, compositions of same, method of making, and methods of using thereof
KR102079347B1 (ko) * 2018-11-30 2020-02-19 문현규 치과용 유닛 체어
KR20220002890A (ko) 2019-03-19 2022-01-07 뵈링거 잉겔하임 애니멀 헬스 유에스에이 인코포레이티드 구충성 아자-벤조티오펜 및 아자-벤조푸란 화합물
PH12021552713A1 (en) * 2019-05-03 2022-07-04 Intervet Int Bv Injectable pharmaceutical compositions and uses thereof
AU2020408351A1 (en) 2019-12-18 2022-08-11 Elanco Tiergesundheit Ag Isoxazoline derivatives as pesticides
FR3107531B1 (fr) * 2020-02-20 2022-02-25 Rl Innovation .composition liquide ou en gel, ecologique permettant l’enlevement des graffittis, chewing-gums, colles, resines sur tous supports poreux ou non ainsi que tous marquages routier
MX2022015038A (es) 2020-05-29 2023-01-04 Boehringer Ingelheim Animal Health Usa Inc Compuestos heterociclicos como anthelminticos.
US20230257370A1 (en) 2020-07-24 2023-08-17 Elanco Us Inc. Process for making an isoxazoline compound and intermediate thereof
CH717763A2 (de) 2020-08-18 2022-02-28 Swibox Ag Abzweigsystem für elektrische Leiter.
JP2024511258A (ja) 2021-01-27 2024-03-13 コルテバ アグリサイエンス エルエルシー 魚における寄生生物に対するシクロプロピルアミド化合物
US20240116854A1 (en) 2021-01-27 2024-04-11 Intervet Inc. Cyclopropylamide compounds against parasites in fish
WO2023156938A1 (en) 2022-02-17 2023-08-24 Boehringer Ingelheim Vetmedica Gmbh Method and system for providing a fluid product mailer
NO20240925A1 (en) 2023-09-15 2025-03-17 Evah Atlantic Inc Dihydroisoxazole compound for use in reducing ectoparasite infestations on fish
WO2025191150A2 (en) 2024-03-15 2025-09-18 Krka, D.D., Novo Mesto Stable isoxazoline formulation for topical application to the skin

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101035431A (zh) * 2004-10-08 2007-09-12 惠氏公司 三亚螨（amitraz）组合物
CN101778566A (zh) * 2007-08-17 2010-07-14 英特威国际有限公司 异噁唑啉组合物及其作为抗寄生虫药的用途
CN101780020A (zh) * 2010-02-09 2010-07-21 广东名臣有限公司 一种清凉、止痒、驱蚊的花露水

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3950360A (en) 1972-06-08 1976-04-13 Sankyo Company Limited Antibiotic substances
US3984564A (en) 1972-06-08 1976-10-05 Sankyo Company Limited Antibiotic substances B-41, their production and their use as insecticides and acaricides
JPS60218303A (ja) * 1984-04-13 1985-11-01 Mitsubishi Chem Ind Ltd 忌避剤組成物
US4916154A (en) 1986-09-12 1990-04-10 American Cyanamid Company 23-Imino derivatives of LL-F28249 compounds
IL98599A (en) 1990-06-28 1995-06-29 Merck & Co Inc Stable salts of 4"-deoxy-4"-epi-methylamino avermectin b1a/b1b and insecticidal compositions containing them
JPH04217606A (ja) * 1990-11-30 1992-08-07 Mitsubishi Gas Chem Co Inc 吸血害虫の吸血阻害剤
US5874479A (en) 1991-03-01 1999-02-23 Warner-Lambert Company Therapeutic permeation enhanced-wound healing compositions and methods for preparing and using same
US5399717A (en) 1993-09-29 1995-03-21 Merck & Co., Inc. Glycosidation route to 4"-epi-methylamino-4"-deoxyavermectin B1
US7906128B2 (en) * 2002-10-21 2011-03-15 Wyeth Llc Use of neuronal sodium channel antagonists for the control of ectoparasites in homeothermic animals
US8119150B2 (en) * 2002-10-25 2012-02-21 Foamix Ltd. Non-flammable insecticide composition and uses thereof
AU2004280158B2 (en) 2003-07-18 2011-02-17 Baxter International, Inc. Methods for fabrication, uses and compositions of small spherical particles prepared by controlled phase separation
US7422215B2 (en) 2003-10-08 2008-09-09 Seven Generations, Inc. Biased card deal
BRPI0508140B1 (pt) 2004-03-05 2015-03-17 Nissan Chemical Ind Ltd Composto benzamida substituída por isoxazolina da fórmula (1); da fórmula (2) substituído por 3,5-bis (aril substituído); da fórmula (4) substituída por alquinibenzeno ou um sal do mesmo; "pesticida, agroquímico, inseticida, parasiticida contendo como ingrediente ativo um ou mais composto benzamida substituída por isoxazolina e sal do mesmo"
PE20060785A1 (es) 2004-10-08 2006-09-19 Wyeth Corp Composiciones de amitraz
TWI368505B (en) 2005-05-24 2012-07-21 Wyeth Corp Versatile high load concentrate compositions for control of ecto-parasites
US7749527B2 (en) 2005-05-24 2010-07-06 Wyeth Llc Gel compositions for control of ecto-parasites
US20060293260A1 (en) † 2005-05-24 2006-12-28 Wyeth Useful high load concentrate compositions for control of ecto-and endo-parasites
TWI412322B (zh) 2005-12-30 2013-10-21 Du Pont 控制無脊椎害蟲之異唑啉
EP2022776A4 (en) * 2006-05-31 2009-10-21 Univ Hokkaido Nat Univ Corp FLUOROAMINES COMPRISING A PERFLUOROALKYL GROUP, PROCESS FOR PRODUCTION THEREOF, FLUOROAMINE FLUORINATION METHOD AND METHOD FOR RECOVERING AN AMIDE COMPRISING A PERFLUOROALKYL GROUP
TW200846029A (en) † 2007-02-09 2008-12-01 Wyeth Corp High dose, long-acting ectoparasiticide for extended control
CL2008001614A1 (es) 2007-06-05 2008-08-08 Wyeth Corp Composicion parasiticida veterinaria que comprende un disolvente que no contiene hidroxilo, un estabilizador, amitraz y opcionalmente una lactona macrociclica y miristato de isopropilo; y su uso para tratar o controlar una infestacion o infeccion par
TWI430995B (zh) 2007-06-26 2014-03-21 Du Pont 萘異唑啉無脊椎有害動物控制劑
EP2957284B1 (en) 2007-06-27 2018-01-17 E. I. du Pont de Nemours and Company Animal pest control method
ES2442342T3 (es) 2008-12-18 2014-02-11 Novartis Ag Derivados de las isoxazolinas y su uso como pesticida
DK2379537T5 (en) 2008-12-19 2017-09-25 Elanco Tiergesundheit Ag Isoxazoline derivatives and their use as pesticides
EP2398318B1 (en) 2009-02-23 2012-12-05 Wyeth LLC Improved-scent ectoparasiticidal formulation
NZ600922A (en) 2009-12-17 2013-10-25 Merial Ltd Anti parasitic dihydroazole compounds and compositions comprising same
CN102933563A (zh) 2010-04-08 2013-02-13 Ah美国42有限责任公司 作为杀虫剂和杀螨剂的取代的3,5-二苯基异噁唑啉衍生物
HUE058291T2 (hu) * 2010-12-27 2022-07-28 Intervet Int Bv Topikális lokalizált izoxazolin formuláció
KR101992589B1 (ko) * 2010-12-27 2019-06-24 인터벳 인터내셔널 비.브이. 글리코푸롤을 포함하는 국소 적용 이속사졸린 제제
WO2018039508A1 (en) 2016-08-25 2018-03-01 Merial, Inc. Method for reducing unwanted effects in parasiticidal treatments

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101035431A (zh) * 2004-10-08 2007-09-12 惠氏公司 三亚螨（amitraz）组合物
CN101778566A (zh) * 2007-08-17 2010-07-14 英特威国际有限公司 异噁唑啉组合物及其作为抗寄生虫药的用途
CN101780020A (zh) * 2010-02-09 2010-07-21 广东名臣有限公司 一种清凉、止痒、驱蚊的花露水

Also Published As

Publication number Publication date
HUE058291T2 (hu) 2022-07-28
DK2658542T3 (da) 2022-03-28
CN103260621A (zh) 2013-08-21
PL2658542T5 (pl) 2025-07-28
US20130281501A1 (en) 2013-10-24
RU2749733C2 (ru) 2021-06-16
AU2016201954B2 (en) 2017-11-23
ZA201304514B (en) 2014-03-26
US20180085352A1 (en) 2018-03-29
CA2822839C (en) 2020-12-29
US10864195B2 (en) 2020-12-15
FI2658542T4 (fi) 2025-09-02
US9173870B2 (en) 2015-11-03
ES2908094T5 (en) 2025-08-12
MX356926B (es) 2018-06-19
PT2658542T (pt) 2022-03-10
JP6514754B2 (ja) 2019-05-15
AU2017254818B2 (en) 2019-08-01
RU2017118161A3 (enExample) 2020-07-30
NZ611476A (en) 2015-10-30
CN105616406A (zh) 2016-06-01
ES2908094T3 (es) 2022-04-27
JP6002148B2 (ja) 2016-10-05
MX383895B (es) 2025-03-14
BR112013015503A2 (pt) 2017-06-27
KR20180125037A (ko) 2018-11-21
AU2016201954A1 (en) 2016-04-21
EP2658542B1 (en) 2022-01-26
MX2013007500A (es) 2013-08-01
RU2633061C2 (ru) 2017-10-11
DK2658542T4 (da) 2025-08-25
US20170071914A1 (en) 2017-03-16
AU2017254818A1 (en) 2017-11-16
CN103260621B (zh) 2016-08-24
JP2018048194A (ja) 2018-03-29
JP6246864B2 (ja) 2017-12-13
AU2011351578A1 (en) 2013-06-20
US9532978B2 (en) 2017-01-03
JP2016222691A (ja) 2016-12-28
RU2017118161A (ru) 2018-10-30
WO2012089622A2 (en) 2012-07-05
WO2012089622A3 (en) 2012-11-15
US20160015689A1 (en) 2016-01-21
CA2822839A1 (en) 2012-07-05
KR102027723B1 (ko) 2019-10-01
EP2658542B2 (en) 2025-06-04
EP2658542A2 (en) 2013-11-06
JP2014504586A (ja) 2014-02-24
PL2658542T3 (pl) 2022-06-20
RU2013135280A (ru) 2015-02-10
KR20130130761A (ko) 2013-12-02

Similar Documents

Publication Publication Date Title
CN105616406B (zh) 外用局部异噁唑啉制剂
JP6539384B2 (ja) グリコフロールを含む経表面局所イソオキサゾリン製剤
KR102193090B1 (ko) 국소 적용 이속사졸린 제제
AU2011351578B2 (en) Topical localized isoxazoline formulation

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant